Table 2. Summary of studies analyzed 5-ALA fluorescence behavior of cerebral metastases.
| First author | Journal | Year | patients with cerebral metastases | 5-ALA positive | % |
|---|---|---|---|---|---|
| Utsuki | Brain Tumor Pathol | 2007 | 11 | 9 | 81.8 % |
| Hefti | SwissMedWkly | 2008 | 2 | 2 | 100% |
| Valdés | JNS | 2011 | 3 | 6/12 samples | 50% |
| Schucht | Acta Neurochirurg | 2011 | 1 | 0 | 0% |
| Kamp | Acta Neurochirurg | 2012 | 52 | 32 | 61.5 % |
| Widhalm | Neurosurg Rev | 2012 | 4 pts. (6 samples) | 3/6 samples (vague) | 50% |
| Suero Molina | Clin Neurol Neurosurg | 2013 | 7 | 7 | 100% |
| Eljamel | Photodiagnosis Photodyn Ther. | 2013 | 5 | 5 (mixed, not red intense) | 100% |
| Marbacher | Neurosurg Focus | 2014 | 65 | 34 | 52% |
| Belloch | Acta Neurochirurg | 2014 | 3 | 1 | 33.3% |
| Piquer | BioMed Research International | 2014 | 3 | 3 | 100% |
| Coburger | Neurosurg Focus | 2014 | 11 | 8 | 72.7% |